
































0Revista Brasileira de Farmacognosia 25 (2015) 258–263
www . sb fgnos ia .org .br / rev is ta
riginal  Article
ypoglycemic  and  hypolipidemic  effects  of  Solidago  chilensis  in  rats
ariane  Schneidera, Adrieli  Sachetta, Amanda  P.  Schönell a,  Eduarda  Ibagya, Emily  Fantina,
ernanda  Bevilaquaa,  Giana  Piccinina, Glaucia  D.  Santoa, Marta  Giachinia, Rafael  Chitolinaa,
ilvana  M.  Wildnera, Ricieri  Mocelinb, Leila  Zanattab, Walter  A.  Roman  Juniorc,∗
Núcleo de Fitoterápicos, Universidade Comunitária da Região de Chapecó, Chapecó, SC, Brazil
Programa de Pós-graduac¸ ão em Ciências Ambientais, Universidade Comunitária da Região de Chapecó, Chapecó, SC, Brazil
Programa de Pós-graduac¸ ão em Ciências da Saúde, Universidade Comunitária da Região de Chapecó, Chapecó, SC, Brazil
 r  t  i  c  l e  i  n  f  o
rticle history:
eceived 18 December 2014
ccepted 16 May  2015





a  b  s  t  r  a  c  t
Solidago  chilensis  Meyen,  Asteraceae,  is  traditionally  used  to treat inﬂammation.  However,  phytochemical
and  pharmacology  investigations  are  lacking.  This study  evaluated  the  hypoglycemic  and  hypolipidemic
effects  of hydroalcoholic  extract  from  S. chilensis  aerial  parts  in  rats. In oral  glucose  tolerance  tests  the
rats received  saline  (0.5  ml/100  g) in  control  group  (C),  hydroalcoholic  extract  (125,  250 or 500  mg/kg
p.o.;  n =  6)  or  glibenclamide  (10  mg/kg  p.o.;  n  = 6). After 30 min,  glucose  (4 g/kg)  was  administered.  Rats
treated  with  hydroalcoholic  extract  500  demonstrated  decreased  glucose  levels  at  180  min  (−22.1%),
when  compared  with  group  C,  similar  to  glibenclamide.  Moreover,  treatment  with  hydroalcoholic  extract
500 signiﬁcantly  increased  the  glycogen  content  in the  liver  and soleus  muscle,  and  hydroalcoholicypoglycemic extract  250 speciﬁcally  inhibited  the  enzyme  maltase  when  compared  with  group  C.  Furthermore,  all
hyperglycemic  rats  treated  with  hydroalcoholic  extract  (125,  250  and  500)  exhibited  an  accentuated
decrease  in total  cholesterol  levels  (−36.8%,  −36.7%  and  −41.3%,  respectively).  Our  results  suggest  that
hypoglycemic  and  hypolipidemic  effects  of  hydroalcoholic  extract  could  be  associated  with  increased
production  and  release  of  insulin  as  well  as  with  insulinotropic  and  antioxidant  effects.
©  2015  Sociedade  Brasileira  de  Farmacognosia.  Published  by  Elsevier  Editora  Ltda.  All  rights  reserved.ntroduction
Diabetes mellitus (DM) comprises a group of disorders involv-
ng distinct pathogenic mechanisms with hyperglycemia as the
ommon denominator (Teixeira et al., 2000). Hyperglycemia in dia-
etes may  be related to numerous physiological events, such as
ecreased glucose in cells, reduced glucose utilization by various
issues, and increased hepatic production of glucose (gluconeo-
enesis) (Prabhakar et al., 2013). Complications experienced by
atients with diabetes are often related to chronic hyperglycemia,
ncluding retinopathy, peripheral vascular disease, renal failure,
europathy, and cardiovascular diseases that cause both morbidity
nd premature mortality (Hirany et al., 2000; Piaulino et al., 2013).
It is well established that patients with type 2 DM frequently
ave abnormal serum lipid proﬁles comprising elevated low
ensity lipoproteins (LDL) and triglycerides levels along with mod-
rately decreased high density lipoproteins (HDL) level (Zimmet,
000), all of which are associated with an increased risk of
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102-695X/© 2015 Sociedade Brasileira de Farmacognosia. Published by Elsevier Editoracardiovascular diseases (Dai et al., 2013). Many studies have shown
that elevated serum cholesterol concentrations can cause coronary
atherosclerosis (Park and Velasquez, 2012) that is associated with
heart disease, stroke, and death in both developed and developing
countries (Raida et al., 2008).
Medicinal plants have been used for many years by different
cultures worldwide to treat DM (Modak et al., 2007). Investigating
herbal medicines has become progressively important in the search
for a new, effective, and safe therapeutic agent to combat DM.  More
than 200 pure bioactive principles isolated from plants have been
shown to lower serum glucose levels (Grover et al., 2002; Warjeet,
2011), including phenolics and ﬂavonoids (Negri, 2005).
Solidago chilensis Meyen, Asteraceae, is a species native to
the southern region of South America. It is widely distributed
in south and southeast Brazil, where it is popularly known as
arnica-do-brasil and is used to relieve inﬂammation (Lorenzi
and Matos, 2002). Its main chemical constituents are ace-
tophenone, carotenes, diterpenoids with labdanic and clerodanic
skeletons (Soares-Valverde et al., 2009), ﬂavonoids, glycosides, 3-
methoxybenzaldehyde, essential oils, and saponins (Silva et al.,
2010), with quercetrin being the major constituent (Torres et al.,
1987).
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Ethnopharmacological investigations have found this species
o have antispasmodic, antihemorrhagic (Alonso, 1998), wound-
ealing (Facury-Neto et al., 2004), and anti-inﬂammatory effects
Tamura et al., 2009). Recently, there has been considerable
rogress in the investigation of S. chilensis and gastric protection
Bucciarelli et al., 2010) as well as a better understanding of the
ffect of S. chilensis on insulin resistance in obese mice (Melo et al.,
011). However, the hypoglycemic and hypolipidemic effects of S.
hilensis on the glucose tolerance curve have not yet been studied.
Therefore, the objective of this study was to investigate the
ypoglycemic and hypolipidemic effects of hydroalcoholic extract
HE) from S. chilensis in rats. This study evaluated the glucose
olerance curve along with, liver and soleus muscle glycogen
evels, disaccharidase activity, total cholesterol (TC), and alanine
minotransferase (ALT) levels. Moreover, the in vitro free radical
cavenging properties of S. chilensis were evaluated.
aterials and methods
lant materials
Aerial parts of Solidago chilensis Meyen, Asteraceae, were col-
ected in Chapecó, SC, Brazil (S 27◦06′38.83′′/W 52◦34′26.52′′). The
oucher specimen was identiﬁed by Osmar dos Santos Ribas and
s deposited in the herbarium of the Botanical Museum of Curitiba
MBM number 356792).
reparation of hydroalcoholic extract
Dried aerial parts of S. chilensis (50 g) of the same particle
ize (300 m;  48 Tyler/Mesch) were macerated in 80% methanol
1000 ml)  for six days. Hydroalcoholic extract (HE) from S. chilensis
as concentrated to dryness under reduced pressure at 40 ◦C and
hen freeze-dried and stored at −20 ◦C.
igh-performance liquid chromatography analysis
Chromatography analysis was performed using a Varian® Pro-
tar HPLC system consisting of an automatic injector, ternary
radient detectors, pumps, and a UV/Vis Kromasil® C18 reversed-
hase ODS column (5 m;  25 mm × 4.5 mm).  The mobile phase
onsisted of two solvents: H2O:acetic acid (40:1, v/v; solvent A)
nd CH3CN (solvent B) that were ﬁltered through 0.45 m Millipore
olytetraﬂuoroethylene membranes. Separations were performed
ith a linear gradient: 86% solvent A and 14% solvent B for
5 min, 35% solvent B for 20 min  and 100% solvent B for 2 min. UV
bsorbance at 360 nm was measured, and the results were com-
ared with the retention times of an authentic external standard
ollowed by a UV spectrum analysis. The ﬂow rate of the mobile
hase was 1 ml/min−1, and the injection volume was 20 l. The
hromatographic runs were performed at 22 ◦C. UV absorbance at
60 nm was measured (Apáti et al., 2006). Quercetrin (12.5, 25,
0, 100 and 200 g/ml; Sigma–Aldrich®) was analyzed in tripli-
ate, and a calibration curve was generated. HE was dissolved in
eOH (1 mg/ml) and ﬁltered through a micropore ﬁlter (0.45 m)
efore the chromatographic proﬁle was generated. The results are
xpressed as the concentration of quercetrin (%) in the dried plant
aterial.
n vitro 2,2-diphenyl-1-picrylhydrazyl free radical scavenging
ssayThe free radical scavenging activity of HE was measured using
he method described by Brand-Williams et al. (1995) with some
odiﬁcations. HE (1 ml;  5–200 g/ml) was added to 2 ml  of a solu-
ion of 2,2-diphenyl-1-picrylhydrazyl (DPPH) radicals in ethanolarmacognosia 25 (2015) 258–263 259
(0.004%). The mixture was  vigorously shaken and allowed to stand
for 30 min  at room temperature (RT). The absorbance (Abssample)
of the resulting solution was measured at 517 nm,  and the antiox-
idant activity (AA) percentage was  calculated using the following
formula:
AA% = 100 − (Abssample − Absblank) × 100
Abscontrol
A solution of ethanol (2 ml)  and HE (1 ml)  was  used as the blank
(Absblank). A solution of DPPH (2 ml)  and ethanol (1 ml)  was used as
the control (Abscontrol). Ascorbic and gallic acids were used as stan-
dards. Free radical scavenging activity was  expressed in terms of
the amount of antioxidants necessary to decrease the initial DPPH
absorbance by 50% (IC50). The IC50 value was  determined by inter-
polation from the nonlinear regression of the plot of percentage of
inhibition against the concentration of HE, which is deﬁned as the
amount of HE needed to scavenge 50% of DPPH radicals.
Animals
The experimental protocol was approved by the Ethics Com-
mittee on Animal Use of the Community University in the Region
of Chapecó, Brazil (CEUA No. 020/2013). Male Rattus norvegicus,
Wistar (n = 30) weighing 250–275 g were used in the study. The
animals were housed in wire-bottomed 17 cm × 33.5 cm × 40.5 cm
cages in a controlled environment at 22 ± 2 ◦C with a 12 h light–dark
cycle and minimal noise. The rats had ad libitum access to water and
commercially prepared rodent chow pellets (Nuvilab® CR-1).
Oral glucose tolerance curve
Animals were fasted overnight and divided into groups con-
taining six rats each. The control group (C), received saline
(0.5 ml/100 g); the HE group received HE (125, 250 or 500 mg/kg)
(Patil et al., 2011); and the glibenclamide group received gliben-
clamide (10 mg/kg) (Zhao et al., 2011). All drugs were diluted with
saline (0.9%) in established doses and administered orally by gav-
age in a volume of 0.5 ml/100 g body weight (Trovato et al., 1996;
Diehl et al., 2001). Glucose levels were measured before the rats
received the treatment (zero time) and 30 min after glucose was
administrated (4 g/kg) (Alam et al., 2011; Pereira et al., 2012). Blood
samples were collected from the tail vein just prior to and 30, 60
and 180 min  after glucose loading, and the glucose level (mg/dl)
was assayed by a glucometer (Accu-Chek® Performa). At the end
of the experimental period, the animals were anesthetized with
a mixture of lidocaine and sodium thiopental (10 and 150 mg/kg,
respectively). Blood aliquots were collected for biochemical analy-
ses via cardiac puncture, and the animals were then euthanized by
exsanguination (Concea, 2012). The liver and soleus were collected
for later analysis, as was a segment of the small intestine.
Glycogen measurements
The harvested liver and soleus were assessed for glycogen con-
tent 3 h after treatment. Glycogen was isolated from these tissues
as described by Krisman (1962). The tissue was  weighed, homoge-
nized in 33% KOH, and boiled at 100 ◦C for 30 min, with occasional
stirring. After cooling, 96% ethanol was  added to the samples, which
were then heated to boiling and cooled in an ice bath to aid glyco-
gen precipitation. The homogenate was centrifuged (1300 × g) for
15 min, the supernatant was  discarded, and the resulting pellet was
washed and resolubilized in water. Glycogen content was deter-
mined by treatment with an iodine reagent, and the absorbance
was measured at 460 nm.  The results were expressed as milligrams
of glycogen per gram of tissue.




























































































Fig. 1. Analysis by high performance liquid chromatography (HPLC): A. quercetrin
(200 g/ml); B. hydroalcoholic extract from aerial parts of Solidago chilensis (1 mg/ml
in  MeOH) (RT: 10.02 min). HPLC Varian® , Kromasil® ODS column (5 M)  reversed
phase C-18 (25 mm × 4.5 mm)  at 24 ± 2 ◦C. Two solvent systems used for analysis;
H2O:acetic acid (40:1, v/v) (solvent A) and CH3CN (solvent B). The ﬂow was 1 ml/min,
and the gradient used had 86% of A for 15 min, 65% of A for 20 min, and 100% of B
for  2 min. The detection by UV was realized at 360 nm.




















Disaccharidase activity was signiﬁcantly affected by HE only at
a dose of 250 mg/kg, as it inhibited maltase activity (F(4, 24) = 3.4;
p < 0.05) compared with group C (Fig. 4).
Table 1
Effects of hydroalcoholic extract from Solidago chilensis on a glucose tolerance curve
(mean ± SEM) (n = 6).
Groups Glucose level (mg/dl)
Initial (time zero) 30 min  60 min 180 min
C 93.6 ± 2.0 128.5 ± 4.6 136.0 ± 1.1 126.0 ± 6.3
HE  125 95.5 ± 2.6 144.6 ± 4.9 150.1 ± 12.7 114.2 ± 5.8
HE  250 100.8 ± 3.2 151.6 ± 20.2 150.1 ± 6.1 114.2 ± 2.6
HE  500 91.0 ± 4.0 148.2 ± 10.1 142.2 ± 1.6 98.2 ± 2.3*60 M. Schneider et al. / Revista Brasilei
isaccharidase extraction and assays
The extracted small intestine segment was washed in 0.9% NaCl
olution, dried on ﬁlter paper, weighed, trimmed, and homoge-
ized (300 × g) with 0.9% NaCl (400 mg  of duodenum per 1.0 ml  of
.9% NaCl) for 1 min  at 4 ◦C. The resulting extract was centrifuged
t (1300 × g) for 8 min. The supernatant was assessed to measure
n vivo maltase, sucrase, and lactase activity as well as protein
etermination. The activity of maltase (EC 3.2.1.20), lactase (EC
.2.1.23), and sucrase (EC 3.2.1.48) was determined using a glucose
iagnosis kit based on the reagent glucose oxidase. To determined
saccharidase activity, duodenum homogenates (10 l) were incu-
ated at 37 ◦C for 60 min  with 10 l of the substrate (equivalent to
.056 M of maltase, sucrase, or lactase) (Dahlqvist, 1984; Pereira
t al., 2011). One enzyme unit (U) was deﬁned as the amount of
nzyme that catalyzed the release of 1 mol  of glucose per minute
nder the assay conditions. The speciﬁc activity was deﬁned as
nzyme activity (U) per milligram of protein. Protein concentration
as determined by the method described by Lowry et al. (1951),
sing bovine serum albumin as the standard. The assays were per-
ormed in duplicate along with appropriate controls.
iochemical analysis of serum samples
Upon collection, serum samples were immediately centrifuged
3000 × g) for 15 min. Serum TC and ALT levels were determined
y enzymatic colorimetric methods (UV/vis) using commercial
abtest® kits according to the manufacturer’s instructions. A semi-
utomated analyzer (BioSystems®, model BTS 310) was used for all
nalysis (Li et al., 2012).
tatistics
All results shown are presented as mean values ± SEM. The data
ere evaluated by one-way ANOVA followed by Tukey’s test and
orrelation analyses using SPSS 20.0. A p-value of <0.05 was con-
idered statistically signiﬁcant.
esults
hemical constituents of S. chilensis
The amount of quercetrin in HE was quantiﬁed by HPLC using
n analytical curve (r = 0.999; y = 0.735x = 2.6971) with a retention
ime of 10.02 min. The HPLC analysis revealed the quercetrin con-
entration to be 2.4% in the aerial parts of S. chilensis (Fig. 1).
etermination of DPPH radical scavenging activity
The DPPH assay showed that HE exhibits antioxidant properties
n vitro (Fig. 2). The highest scavenging effect was observed for HE,
ith an IC50 of 59.12 ± 3.14 g/ml, although it showed lower scav-
nging abilities than ascorbic and gallic acids, which were used as
tandards (16.32 ± 2.94 and 2.14 ± 1.58 g/ml, respectively).
ffect of HE on the oral glucose tolerance curve
Table 1 shows that HE500 had a signiﬁcant antihyperglycemic
ffect when compared to the C group (F(4, 21) = 12.0; p < 0.05). Lower
erum glucose (approx. 22% lower) was detected 180 min  after
reatment; glibenclamide showed similar results.ffect of HE on hepatic and soleus glycogen content
Fig. 3 shows that HE and glibenclamide did not affect hepatic and
oleus glycogen content compared with other treatment groups.Fig. 2. 2,2-Diphenyl-1-picrylhydrazyl (DPPH) radical scavenger activity of hydroal-
coholic extract from Solidago chilensis (HE) compared with standards ascorbic and
gallic acids. Results are expressed as means ± SEM (n = 3).
However, HE 500 signiﬁcantly increased hepatic (F(4, 25) = 6.6;
p < 0.05) and soleus (F(4, 23) = 3.9; p < 0.05) glycogen content com-
pared with group C.
Effect of HE on disaccharidase activityGLIB 93.3 ± 1.1 149.8 ± 5.5 149.3 ± 3.5 78.5 ± 8.9*
C, control; HE, hydroalcoholic extract from S. chilensis (125, 250 or 500 mg/kg); GLIB,
glibenclamide (10 mg/kg).
* p < 0.05. One-way ANOVA, compared to group C in the respective time.
M. Schneider et al. / Revista Brasileira de Farmacognosia 25 (2015) 258–263 261

















































































Fig. 5. The effects of treatments on total cholesterol (TC) values (mean ± SEM; n = 6).
Hyperglycemic rats were given saline (control group; C) or the following treatments:00 mg/kg) and glibenclamide (GLIB; 10 mg/kg) on hepatic and soleus glycogen con-
ent in hyperglycemic rats. Values are expressed as mean ± SEM (n = 6). *p < 0.05
ne-way ANOVA compared to the control group (C).
ffects of HE on TC and ALT
Following treatment, group C rats had higher serum TC than
ats in the other groups. All hyperglycemic rats treated with
E (125, 250 or 500) exhibited an accentuated decrease in TC
−36.8%, −36.7% and −41.3%, respectively), compared with group C

























ig. 4. Effect of hydroalcoholic extract from Solidago chilensis (HE; 125, 250 and
00 mg/kg) and glibenclamide (GLIB; 10 mg/kg) on the speciﬁc activity of maltase,
n  a segment of the small intestine. Values are expressed as mean ± SEM (n = 6).
p  < 0.05 one-way ANOVA compared to control group saline (C).hydroalcoholic extract from Solidago chilensis (HE; 125, 250 or 500 mg/kg); gliben-
clamide (GLIB; 10 mg/kg). *p < 0.05 one-way ANOVA compared to control group
saline (C).
(F(4, 23) = 5.7; p < 0.05; Fig. 5). There was no difference in serum ALT
activity between the groups (data not shown).
Discussion
Diabetes mellitus is a chronic metabolic disorder characterized
by hyperglycemia. It is associated with alterations in carbohy-
drate, protein, and lipid metabolism (Pereira et al., 2011). Plants
exert antihyperglycemic and hypoglycemic activity primarily via
their ability to restore pancreatic tissue function by increasing
insulin output, inhibit intestinal absorption of glucose, or facilitate
metabolites in insulin-dependent processes (Patel et al., 2012).
The present study showed that a glucose dose of 4 g/kg can con-
siderably increase rats serum glucose levels, which were mitigated
by a single oral dose of HE at 500 mg/kg for 180 min following
glucose administration. Recently, it was demonstrated that rutin
reduces serum glucose levels and potentiates in vivo insulin secre-
tion (Kappel et al., 2013); rutin mechanism of action can also be
explained by mammals synthesizing glycogen to maintain appro-
priate glucose levels. Glycogen is how mammals store glucose
for future use, mainly in skeletal muscles and the liver (Jensen
et al., 2011). Insulin and glucagon regulate glycogen metabolism
by activating and inhibiting several enzymes and proteins (Ferrer
et al., 2003); the healthy organism removes serum glucose rapidly
when glucose is in excess, but insulin-stimulated glucose disposal is
reduced inorganisms with insulin resistance and type 2 DM (Jensen
et al., 2011). In the present study, rats administered HE 500 had
signiﬁcantly increased glycogen content in the liver and soleus
compared with rats in group C, which helped lead to the HE 500 rats
lower serum glucose levels. In agreement with Torres et al. (1987),
the phytochemical analysis by HPLC conﬁrmed that the quercetrin
ﬂavonoid is the major bioactive substance of S. chilensis. Flavonoids
may  exert beneﬁcial effects in DM by enhancing insulin secre-
tion; reducing apoptosis and promoting proliferation of pancreatic
-cells; improving hyperglycemia through regulating hepatocyte
glucose metabolism; reducing insulin resistance, inﬂammation,
and oxidative stress in muscle and fat; and increasing glucose
uptake in skeletal muscle and white adipose tissue (Babu et al.,
2013). This ﬁnding is in agreement with Prasath and Subramanian
(2011), who  reported the antidiabetic effect of the ﬂavonoid ﬁsetin
(tetrahydroxyﬂavone) in a study conducted with diabetic rats. Oral
administration reduced serum glucose and increased serum insulin
concentrations. Further, treatment with HE 500 increased glycogen
levels and the activity of glycogen synthase, whereas it suppressed
glycogen phosphorylase, suggesting that ﬂavonols may  improve
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lucose homeostasis by modulating enzymes that regulate carbo-
ydrate metabolism. It was also demonstrated that kaempferitrin,
he major ﬂavonoid found in Bauhinia forﬁcata Link., leaves, is able
o diminish serum glucose levels and increase glucose uptake in
he rat soleus as efﬁciently as insulin (Jorge et al., 2004). This effect
ould be related to the increased muscle glycogen content seen in
he present study with the HE 500 treatment.
In the present study, we demonstrated that HE 250 reduced
altase activity. Several plants exert antihyperglycemic activ-
ty via inhibiting enzymes that hydrolyze carbohydrates in the
mall intestine, and the effect appears to involve interactions with
olyphenolic compounds (Mai  and Chuyen, 2007). Although HE 500
ore signiﬁcantly lowered rats serum glucose levels, it did not sig-
iﬁcantly inhibit maltase activity. This ﬁnding is in agreement with
ereira et al. (2011, 2012), who found that higher doses of extracts
nd substances, did not affect disacharidase activity. These ﬁnd-
ngs reinforce the idea that HE affects serum glucose by increasing
lucose storage (as glycogen) in the liver and muscle.
Rats treated with HE (125, 250 or 500 mg/kg) showed decreased
erum TC. A previous study using other plants suggested that
hese effects can be attributed to the restoration of triacylglyceride
atabolism by stimulating lipolytic pathways involving plasma
ipoprotein lipase (Xie et al., 2007). In the present study, HE could
ave stimulated similar effects. Intracellular glucose and lipid
etabolic disorders are the basis of a variety of metabolic diseases.
lucose and lipid metabolic disorders are closely related to the
ccurrence and progression of DM,  obesity, hepatic steatosis, and
ardiovascular disease (Meng et al., 2013).
We  cannot discount the possibility that HE also interferes with
holesterol’s metabolic cycle at other points, such as intestinal
ptake, endogenous metabolism, and transport by lipoproteins (Bei
t al., 2012; Roman-Junior et al., 2015), which were not assessed in
his study.
Free radical scavenging properties of S. chilensis were observed
n the DPPH assay. Thus, we propose that the plants hydroal-
oholic extract may  have contributed to the hyperglycemic rats
mproved lipid metabolism and oxidative stress. This is character-
stic of polyphenols (Liu et al., 2014); however, further studies are
equired to conﬁrm the in vivo antioxidant effects of S. chilensis
nd its beneﬁts in hypoglycemic and hypercholesterolemic ani-
al  models. Levels of ALT did not differ between treatment groups,
ndicating the absence of HE toxicity at the doses tested.
In summary, our results showed that HE exerted marked hypo-
lycemic effects via increasing the production and release of insulin
s well as via increasing insulinotropic activity. The hypolipi-
emic effect of HE in rats possibly involved reduced levels of
ipoproteins as well as antioxidant activity. Furthermore, there was
trong evidence that quercetrin, the major constituent of S. chilensis
xtracts, is largely responsible for the observed biological activities.
owever, the underlying mechanisms of these effects need to be
lucidated by further studies.
onclusions
Hydroalcoholic extract of S. chilensis may  be effective in main-
aining glucose homeostasis by reducing serum glucose levels and
C.
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